The effect of erlotinib after gefitinib failure in advanced non-small cell lung cancer (NSCLC) patients with poor performance status (PS): A matched-pair case-control study.
M. Huang
No relevant relationships to disclose
D. Luo
No relevant relationships to disclose
X. Zhang
No relevant relationships to disclose
M. Yu
No relevant relationships to disclose
B. Zou
No relevant relationships to disclose
Y. Li
No relevant relationships to disclose
J. Long
No relevant relationships to disclose
J. Wang
No relevant relationships to disclose
F. Peng
No relevant relationships to disclose
Y. Xu
No relevant relationships to disclose
L. Li
No relevant relationships to disclose
L. Ren
No relevant relationships to disclose
M. Hou
No relevant relationships to disclose
Y. Lu
No relevant relationships to disclose